Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort

Overview

Journal J Clin Cell Immunol

Publisher Omics Publishing Group

Date 2014 Nov 25

PMID 25419480

Citations 7

Authors

Rachel Gross

Jennifer Graybill

Dawn Wahezi

Nicole C Jordan

Chaim Putterman

Irene Blanco

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the factors associated with medication compliance in a multi-ethnic population of patients with systemic lupus erythematosus in an urban community.

Methods: We surveyed patients in our cohort using the standardized measures of the Compliance-Questionnaire-Rheumatology (CQR), the Beliefs about Medications Questionnaire (BMQ), as well as patient self-reported compliance. Demographic and clinical characteristics of compliant and non-compliant patients underwent bivariate analysis. A multivariate analysis was then performed on variables of interest.

Results: Of the 94 patients who agreed to participate in the survey, 89 fully completed each questionnaire. Overall, 48% of patients were compliant by CQR. In multivariate analyses, higher education level was associated with non-compliance. Spanish-speaking patients and those with an income of greater than $15,000 per year were more likely to be compliant.

Conclusions: In this urban lupus population, several factors may influence medication compliance. Factors associated with non-compliance are not what have been found in other populations. Further studies looking into specific reasons for certain areas of non-compliance as well as addressing these issues will be important in both treatment and outcomes in lupus patients in implementing appropriate interventions.

Citing Articles

Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.

Emamikia S, Gomez A, Adahl T, von Perner G, Enman Y, Chatzidionysiou K Lupus. 2024; 33(6):615-628.

PMID: 38545763 PMC: 11015713. DOI: 10.1177/09612033241242692.

Self-reported medication information needs among medication users in a general population aged 40 years and above - the Tromsø study.

Walquist M, Svendsen K, Garcia B, Bergmo T, Eggen A, Halvorsen K BMC Public Health. 2022; 22(1):2182.

PMID: 36434564 PMC: 9700964. DOI: 10.1186/s12889-022-14573-z.

An Overview on Causes of Nonadherence in the Treatment of Rheumatoid Arthritis: Its Effect on Mortality and Ways to Improve Adherence.

Chowdhury T, Dutta J, Noel P, Islam R, Gonzalez-Peltier G, Azad S Cureus. 2022; 14(4):e24520.

PMID: 35651472 PMC: 9136714. DOI: 10.7759/cureus.24520.

Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China.

Zhang L, Lu G, Ye S, Wu B, Shen Y, Li T Patient Prefer Adherence. 2017; 11:1591-1601.

PMID: 29075106 PMC: 5609799. DOI: 10.2147/PPA.S144624.

A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.

Goh H, Kwan Y, Seah Y, Low L, Fong W, Thumboo J Rheumatol Int. 2017; 37(10):1619-1628.

PMID: 28681249 DOI: 10.1007/s00296-017-3763-9.

References

Fernandez M, Alarcon G, Calvo-Alen J, Andrade R, McGwin Jr G, Vila L . A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007; 57(4):576-84. DOI: 10.1002/art.22672. View

Danchenko N, Satia J, Anthony M . Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006; 15(5):308-18. DOI: 10.1191/0961203306lu2305xx. View

Chambers S, Raine R, Rahman A, Isenberg D . Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Rheumatology (Oxford). 2009; 48(3):266-71. DOI: 10.1093/rheumatology/ken479. View

Alarcon G, Friedman A, Straaton K, Moulds J, Lisse J, Bastian H . Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999; 8(3):197-209. DOI: 10.1191/096120399678847704. View

Borchers A, Naguwa S, Shoenfeld Y, Gershwin M . The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev. 2009; 9(5):A277-87. DOI: 10.1016/j.autrev.2009.12.008. View

Petri M, Perez-Gutthann S, Longenecker J, Hochberg M . Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 1991; 91(4):345-53. DOI: 10.1016/0002-9343(91)90151-m. View

Alarcon G, McGwin Jr G, Bastian H, Roseman J, Lisse J, Fessler B . Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 2001; 45(2):191-202. DOI: 10.1002/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO;2-2. View

Alarcon G, Roseman J, Bartolucci A, Friedman A, Moulds J, Goel N . Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998; 41(7):1173-80. DOI: 10.1002/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO;2-A. View

Bauerle Bass S, Ruzek S, Gordon T, Fleisher L, McKeown-Conn N, Moore D . Relationship of Internet health information use with patient behavior and self-efficacy: experiences of newly diagnosed cancer patients who contact the National Cancer Institute's Cancer Information Service. J Health Commun. 2006; 11(2):219-36. DOI: 10.1080/10810730500526794. View

10.

van Uden-Kraan C, Drossaert C, Taal E, Smit W, Seydel E, van de Laar M . Experiences and attitudes of Dutch rheumatologists and oncologists with regard to their patients' health-related Internet use. Clin Rheumatol. 2010; 29(11):1229-36. PMC: 2943066. DOI: 10.1007/s10067-010-1435-1. View

11.

Gilmer T, Ojeda V, Barrio C, Fuentes D, Garcia P, Lanouette N . Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited English proficiency. Psychiatr Serv. 2009; 60(2):175-82. PMC: 3235435. DOI: 10.1176/appi.ps.60.2.175. View

12.

Garcia Popa-Lisseanu M, Greisinger A, Richardson M, OMalley K, Janssen N, Marcus D . Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol. 2005; 32(5):913-9. View

13.

Chambers S, Raine R, Rahman A, Hagley K, de Ceulaer K, Isenberg D . Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica. Lupus. 2008; 17(8):761-9. DOI: 10.1177/0961203308089404. View

14.

Duran S, Apte M, Alarcon G . Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc. 2007; 99(10):1196-8. PMC: 2574398. View

15.

Mosley-Williams A, Lumley M, Gillis M, Leisen J, Guice D . Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum. 2003; 47(6):630-8. DOI: 10.1002/art.10790. View

16.

Kowalczyk N, Draper L . Trends in patient information preferences and acquisition. Radiol Technol. 2012; 83(4):316-24. View

17.

David R, Rhee M . The impact of language as a barrier to effective health care in an underserved urban Hispanic community. Mt Sinai J Med. 1998; 65(5-6):393-7. View

18.

van den Bemt B, van den Hoogen F, Benraad B, Hekster Y, van Riel P, van Lankveld W . Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol. 2009; 36(10):2164-70. DOI: 10.3899/jrheum.081204. View

19.

Blackhall L, Murphy S, FRANK G, Michel V, Azen S . Ethnicity and attitudes toward patient autonomy. JAMA. 1995; 274(10):820-5. View

20.

Nived O, Andersson M, Lindgren M, Malcus-Johnsson P, Nihlberg A, Nived K . Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: a study with a questionnaire. Lupus. 2007; 16(9):701-6. DOI: 10.1177/0961203307080635. View